Stock News
Sanara MedTech Inc. Announces Exciting Changes to Board of Directors in 2024!
Sanara MedTech Inc. Announces Changes to Board of Directors Fort Worth, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) — Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound, and skincare…
Sunlight Financial Holdings Inc. Faces Securities Fraud Lawsuit: A Quirky Twist in the Stock Market
Welcome to the World of Securities Class Action Lawsuits: A Funny and Quirky Look at the Cross River Bank Case Introduction Are you ready for some legal drama? Well, buckle up because we’ve got a juicy securities class action lawsuit to discuss! Berger Montague PC has filed a lawsuit against Cross River Bank, the Bank…
Maximizing Your Investment: Main Street Financial Services Corp. Introduces Dividend Reinvestment Plan for Shareholders
Main Street Financial Services Corp. Implements Dividend Reinvestment Plan Introduction On October 7, 2024, Main Street Financial Services Corp. (OTCQX:MSWV) announced the implementation of a Dividend Reinvestment Plan (DRIP) as part of the Computershare Investment Plan. This new plan will offer eligible shareholders the opportunity to automatically reinvest their dividends in reinvestment shares. Details of…
Analog Devices Launches CodeFusion Studio and Developer Portal for Simplified and Efficient Embedded Software Development at the Intelligent Edge
Analog Devices Launches CodeFusion Studio and Developer Portal Simplified and Efficient Embedded Software Development at the Intelligent Edge By: [Your Name] Professionally, educated, profit-focused, and intense, Analog Devices has taken a significant leap forward in the world of embedded software development with the launch of CodeFusion Studio™ and a new Developer Portal. These new offerings…
Galecto’s Exciting Shift: Focusing on Oncology and Liver Disease, Plus a New Preclinical Asset for Acute Myeloid Leukemia!
Welcome to Galecto, Inc.: Where Innovation Meets Impact Exciting News from Galecto, Inc. On October 7, 2024, Galecto, Inc. made a groundbreaking announcement that is sure to shake up the world of biotechnology. The clinical-stage company, known for its focus on developing novel treatments for cancer and fibrosis, revealed that it will be shifting its…
Breaking News: Quantum BioPharma Ltd. Expands Reach with Master Distribution Agreement for Celly Nutrition in Puerto Rico, The Caribbean, and Central and South America
Quantum BioPharma Ltd. Launches new Beverage Product, unbuzzd™ Toronto, Ontario–(Newsfile Corp. – October 7, 2024) – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (“Quantum BioPharma”) provides an update by way of a news release issued by Celly Nutrition Corp. (“Celly Nu” or the “Company”) Quantum BioPharma Ltd. has recently announced the launch of…
Join Us Virtually on October 14, 2024 for Moleculin’s Acute Myeloid Leukemia KOL Event!
Exciting News in the Fight Against Acute Myeloid Leukemia Live Webcast Discussion with Key Opinion Leaders Recently, Moleculin Biotech, Inc. announced that they will be hosting a virtual event featuring internationally renowned Acute Myeloid Leukemia (AML) Key Opinion Leaders. This live webcast will focus on the ongoing progress of the pivotal, adaptive Phase 3 clinical…
Inozyme Pharma Welcomes Biopharmaceutical Leader Erik Harris to Board of Directors
Welcome to our Blog Post! Inozyme Pharma, Inc. Appoints Erik Harris to its Board of Directors Boston, Oct. 07, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood vessel function, today announced the appointment of…